Sun Pharma Expects India Business To Normalise In 2018-19
Employees enter the Sun Pharmaceutical Industries Ltd. corporate office in the Andheri suburb of Mumbai, India. (Photographer: Amit Madheshiya/Bloomberg).

Sun Pharma Expects India Business To Normalise In 2018-19

Bookmark
Sun Pharmaceuticals Industries Ltd. expects its India business to stabilise in the current fiscal leading to “reasonable volume growth” after disruptions in the previous year due to the implementat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.